University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Salicylic acid 5% w/w in emulsifying ointment

Unlicensed special
Status: Green Saliva artificial spray (Saliveze)

Approved for ACBS conditions, e.g. dry mouth (xerostomia) as a result of having (or having undergone) radiotherapy, or sicca syndrome. Palliative Care, Dental practitioners  
Status: Green Salivix® pastilles

Approved for ACBS conditions, e.g. dry mouth (xerostomia) as a result of having (or having undergone) radiotherapy, or sicca syndrome. Palliative Care, dental practitioners.
Status: Green Salmeterol inhaler

Prescribe by brand to ensure patients receive the device they are used to. Check licensed indication (differences among brands). Be aware of differences in excipients among the different brands- APC listing of current formulary brands
Status: Red Sebelipase alfa (Kanuma®)

For Wolman disease
Status: Amber Selegiline lyophisilate

For patients with swallowing difficulties only
Status: Red Semaglutide (Wegovy®)

The use of semaglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place.

Prescribe by brand (Wegovy®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes.

The Wegovy® brand of semaglutide is not commercially available yet.
Status: Amber Sevelamer tablets

Specialist recommendation.
Status: Red Sildenafil injection

Hospital use only. NHS England commissioned.
Status: Red Sildenafil tablets

Hospital use only. NHS England commissioned.
Building healthier lives
Back to top